How to appeal a UnitedHealthcare chronic wound care denial

The framework that applies to your appeal

Federal law gives you the right to a full and fair internal appeal, then an external review by an independent third party.

UnitedHealthcare-specific note: UHC's parent UnitedHealth Group owns Optum (PBM Optum Rx) and Surest. Surest plans have different cost-sharing rules. State complaints flow to state insurance department + DOL/EBSA for self-funded.

What UnitedHealthcare's policy requires for chronic wound care

Cited policy: UHC Commercial Medical Policy: Hyperbaric Oxygen Therapy and Topical Oxygen Therapy

Patterned on CMS NCD 20.29: type 1/2 DM, lower-extremity wound classified Wagner Grade 3 or higher, failed >=30 consecutive days of standard wound care with no measurable signs of healing, evaluated for adequate vascular supply. Up to 40 sessions covered without re-evaluation; continued sessions require documented progress every 30 days. UHMS-accredited facility preferred.

How UnitedHealthcare denies chronic wound care — and how to counter it

Where UnitedHealthcare pushes back: 1) Wagner Grade 2 not eligible; 2) Inadequate documentation of >=30 days standard care; 3) TcPO2 not measured; 4) ABI within normal limits suggesting non-ischemic wound (HBOT not needed).

Counter-arguments that hold up: Wagner 2 with confirmed osteomyelitis (probe-to-bone + MRI) functionally upgrades to Wagner 3 per UHMS 14th Edition + Noridian LCD interpretation. NCD 20.29 does NOT mandate TcPO2 — ABI + Wagner staging + clinical course suffice (Fife UHM 2002 supports TcPO2 as predictor not gatekeeper). Cite Faglia Diabetes Care 1996 (major amputation 8.6% vs 33.3%, p=0.016) + Londahl HODFU Diabetes Care 2010 (52% vs 29% complete healing at 1 yr, p=0.03) + SVS/APMA/SVM 2016 J Vasc Surg adjunctive recommendation for non-healing DFU after 4 wk standard care.

What UnitedHealthcare typically denies for chronic wound care

Across UnitedHealthcare's commercial and Medicare books, denials cluster around a small number of patterns. For chronic wound care, expect:

• GLP-1 weight-loss exclusion
• Out-of-network reduction citing UCR
• Step therapy on biologics
• Prior auth denied for advanced imaging
• Quantity limits on specialty drugs

Treatments most often denied in this category

These are the chronic wound care treatments most often flagged for prior auth, step therapy, or medical necessity review:

• HBOT
• NPWT (wound vac)
• Apligraf
• Dermagraft
• EpiFix (dHACM)
• Grafix

How to submit the appeal to UnitedHealthcare

1. Read the denial letter — note the exact denial reason code and the appeal deadline (180 days from the date on the letter).
2. Gather supporting documentation: physician letter of medical necessity, relevant clinical notes, peer-reviewed citations supporting the treatment for your indication, and the policy or coverage document UnitedHealthcare cited in the denial.
3. File the appeal through UnitedHealthcare's portal (members: https://www.myuhc.com ; providers: https://www.uhcprovider.com). Standard decision returns within 30 days; expedited urgent appeals return within 72 hours.
4. If denied again, request external review by an independent reviewer within 4 months of the final internal denial. In MN, the state insurance department coordinates external review for fully-insured plans; ERISA self-funded plans use a federal external review through DOL/EBSA.

Clinician or prior-auth team handling this on the practice side? See UnitedHealthcare's prior-authorization criteria by drug: UnitedHealthcare PA criteria on ApprovalHelp.